http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2162692-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d62439409b1cd88b2de6fd5934f6e7f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-02 |
| filingDate | 1999-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2001-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ed9e1db250890708f5924459ba3f925 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2e9c356dc702c521a883fd2dd251cbe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42f75828bfbbe4ecaa13eb1377919849 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80e111a48fd6f85b400834b6d9d2af64 |
| publicationDate | 2001-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2162692-C1 |
| titleOfInvention | Composition based on perfluoroorganic compound emulsion for medical-biological aims |
| abstract | FIELD: medicine. SUBSTANCE: invention relates to preparing compositions based on perfluorocarbon emulsions used as artificial blood substitutes, contrasting agents and media for organs conservation and storage. Invention involves preparing blood substituting compositions based on perfluorocarbon emulsions with decreased degree of adverse effects and transient presence of perfluoroorganic compounds in body. For preparing blood substituting compositions mixtures consisting of 2, 3, 4 perfluoroorganic compounds are used: perfluorodecaline, perfluorooctyl-bromide, perfluoromethylcyclo-hexylpiperidine, perfluorotributylamine taken in the different ratios and emulsified with proxanol (or phospholipids) followed by addition of electrolyte solution to prepared emulsion up to achievement of perfluorocarbons concentration from 1% to 20% and proxanol from 0.4% to 4.8%. EFFECT: improved medical-biological and physical-chemical indices of blood substituting compositions, broadened area of perfluorocarbon blood substitutes using. 5 cl, 1 tbl, 5 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7842730-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8900562-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020209752-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2518313-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2745290-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9000048-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007525536-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007105978-A1 |
| priorityDate | 1999-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.